By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Trevena, Inc. 

Berwyn  Pennsylvania    U.S.A.
Phone: n/a Fax: n/a



Drug Discovery

Company News
Trevena, Inc. (TRVN) Initiates Second Phase 2b Study Of TRV130 For Acute Postoperative Pain 1/7/2015 10:53:05 AM
Trevena, Inc. (TRVN) Appoints Anne M. Phillips To The Board Of Directors 12/17/2014 10:20:06 AM
Trevena, Inc. (TRVN) Announces Closing Of Public Offering And Partial Exercise Of Underwriters’ Option To Purchase Additional Shares 12/11/2014 7:43:37 AM
Trevena, Inc. (TRVN) Announces Pricing Of Public Offering 12/5/2014 3:20:20 PM
Trevena, Inc. (TRVN) Planning $40M Stock Offering 12/3/2014 7:44:26 AM
Trevena, Inc. (TRVN) Announces Commencement Of Public Offering 12/1/2014 11:58:26 AM
Trevena, Inc. (TRVN) Announces Positive Top-Line Results From Phase 2a/b Study Of TRV130 In Acute Postoperative Pain 11/18/2014 5:58:49 AM
Trevena, Inc. (TRVN) Reports Third Quarter 2014 Financial Results And Provides A Corporate Update 11/11/2014 9:23:36 AM
Trevena, Inc. (TRVN) Announces Early Completion Of Enrollment Of Phase 2a/B Study Of TRV130 In Postoperative Pain 10/8/2014 10:06:57 AM
Trevena, Inc. (TRVN) Enters Into $35 Million Tranched Term Loan Credit Facility 9/22/2014 8:40:09 AM